Total Payments
$1,396
2024 Payments
$393.04
Companies
16
Transactions
62
Medicare Patients
9,513
Medicare Billing
$3.5M
Payment Breakdown by Category
Food & Beverage$1,364 (97.7%)
Education$31.85 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,364 | 60 | 97.7% |
| Education | $31.85 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $209.22 | 11 | $0 (2024) |
| Genentech USA, Inc. | $178.31 | 10 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $172.16 | 8 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $148.83 | 5 | $0 (2021) |
| OPTOVUE, INC. | $140.68 | 2 | $0 (2019) |
| Allergan Inc. | $102.42 | 2 | $0 (2017) |
| Alimera Sciences, Inc. | $99.52 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $96.17 | 4 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $69.42 | 4 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $45.20 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $393.04 | 19 | Genentech USA, Inc. ($122.10) |
| 2023 | $144.64 | 8 | Astellas Pharma US Inc ($46.58) |
| 2022 | $66.08 | 4 | Regeneron Healthcare Solutions, Inc. ($33.54) |
| 2021 | $112.67 | 7 | Bausch & Lomb, a division of Bausch Health US, LLC ($41.28) |
| 2020 | $91.55 | 5 | Bausch & Lomb, a division of Bausch Health US, LLC ($60.53) |
| 2019 | $360.22 | 13 | Novartis Pharmaceuticals Corporation ($129.78) |
| 2018 | $88.52 | 2 | OPTOVUE, INC. ($77.26) |
| 2017 | $138.95 | 4 | Allergan Inc. ($102.42) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Amgen Inc. | PAVBLU (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/13/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Dry eyes | ||||||
| 07/31/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Ophthalmology | ||||||
| 05/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Ophthalmology | ||||||
| 05/21/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: Ophthalmology | ||||||
| 05/15/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/31/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 01/09/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Education | In-kind items and services | $17.19 | General |
| Category: Ophthalmology | ||||||
| 11/29/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/24/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $22.45 | General |
| 09/22/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/20/2023 | Alimera Sciences, Inc. | YUTIQ (Drug) | Food and Beverage | Cash or cash equivalent | $12.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/18/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $24.13 | General |
| 07/12/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,340 | 14,461 | $2.6M | $935,790 |
| 2022 | 22 | 2,275 | 6,076 | $2.3M | $787,362 |
| 2021 | 21 | 2,432 | 5,886 | $2.6M | $934,240 |
| 2020 | 21 | 2,466 | 5,861 | $2.5M | $877,132 |
Total Patients
9,513
Total Services
32,284
Medicare Billing
$3.5M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 88 | 588 | $817,600 | $402,641 | 49.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 61 | 9,601 | $477,000 | $276,986 | 58.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 226 | 834 | $655,980 | $69,742 | 10.6% |
| 92134 | Imaging of retina | Office | 2023 | 650 | 1,553 | $308,234 | $47,681 | 15.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 361 | 409 | $78,495 | $34,359 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 275 | $44,775 | $25,433 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 251 | 348 | $40,020 | $22,911 | 57.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 118 | 362 | $36,200 | $18,986 | 52.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $19,970 | $10,052 | 50.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 90 | 90 | $20,205 | $10,047 | 49.7% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 19 | 25 | $32,524 | $9,826 | 30.2% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 13 | 14 | $16,702 | $2,547 | 15.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 24 | 24 | $3,120 | $1,170 | 37.5% |
| 92250 | Photography of the retina | Office | 2023 | 27 | 29 | $3,555 | $854.07 | 24.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 20 | 24 | $5,946 | $816.77 | 13.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 36 | 37 | $1,850 | $687.40 | 37.2% |
| 68200 | Injection into conjunctiva | Office | 2023 | 15 | 23 | $3,151 | $681.63 | 21.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 20 | 23 | $1,150 | $272.36 | 23.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 120 | $1,800 | $96.38 | 5.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 89 | 600 | $834,400 | $427,110 | 51.2% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2022 | 12 | 270 | $90,450 | $66,257 | 73.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 212 | 788 | $615,420 | $64,782 | 10.5% |
| 92134 | Imaging of retina | Office | 2022 | 641 | 1,508 | $298,584 | $46,332 | 15.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 360 | 402 | $72,360 | $33,463 | 46.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 13 | 1,020 | $51,000 | $30,438 | 59.7% |
About Dr. Eliot Foley, MD
Dr. Eliot Foley, MD is a Ophthalmology healthcare provider based in Manchester, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528069424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eliot Foley, MD has received a total of $1,396 in payments from pharmaceutical and medical device companies, with $393.04 received in 2024. These payments were reported across 62 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,364).
As a Medicare-enrolled provider, Foley has provided services to 9,513 Medicare beneficiaries, totaling 32,284 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Manchester, NH
- Active Since 08/02/2005
- Last Updated 07/01/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1528069424
Products in Payments
- OCT (Device) $140.68
- VYZULTA (Drug) $134.19
- EYLEA (Biological) $130.29
- Vabysmo (Drug) $117.33
- RESTASIS (Drug) $102.42
- EYLEA HD (Biological) $78.93
- YUTIQ (Drug) $75.12
- Izervay (Drug) $49.59
- Syfovre (Drug) $45.20
- XELPROS (Drug) $39.58
- LOTEMAX SM (Drug) $37.97
- XIIDRA (Drug) $31.27
- Cequa (Drug) $29.84
- MIEBO (Drug) $24.98
- TearLab Osmolarity System (Device) $24.63
- VUITY (Drug) $19.39
- TYRVAYA (Drug) $19.25
- BEOVU (Drug) $19.05
- Susvimo (Drug) $18.83
- VABYSMO (Drug) $17.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Manchester
Ahad Fazelat, M.d, M.D
Ophthalmology — Payments: $8,451
Ophthalmology $8,451
Richard Fichman, M.d, M.D
Ophthalmology — Payments: $3,287
Ophthalmology $3,287
Stephanie Choi
Ophthalmology — Payments: $2,935
Ophthalmology $2,935
Dr. Steve Tu, D.o, D.O
Ophthalmology — Payments: $2,724
Ophthalmology $2,724
Marion Stoj, M.d, M.D
Ophthalmology — Payments: $1,929
Ophthalmology $1,929
Dr. Jason Hall, M.d, M.D
Ophthalmology — Payments: $1,743
Ophthalmology $1,743